PUNE, India, June 16, 2025 /PRNewswire/ -- amber, a global student housing solutions provider, has launched the industry's first-ever global 'amber…
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever…